Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Gross Profit | -4,000 | -3,000 | -3,000 | -3,000 | -3,000 |
| Selling General And Administration | 983,000 | 1.0M | 704,000 | 861,000 | 898,000 |
| General And Administrative Expense | 983,000 | 1.0M | 704,000 | 861,000 | 898,000 |
| Other Operating Expenses | 4,000 | 35,000 | 25,000 | 47,000 | 64,000 |
| Operating Expense | 987,000 | 1.1M | 729,000 | 908,000 | 962,000 |
| Operating Income | -991,000 | -1.1M | -732,000 | -911,000 | -965,000 |
| EBIT | -1.8M | -914,000 | -732,000 | -809,000 | -724,000 |
| Interest Expense | 1,000 | 0.00 | -- | 0.00 | 0.00 |
| Interest Expense Non Operating | 1,000 | 0.00 | -- | 0.00 | 0.00 |
| Interest Income | 47,000 | 52,000 | 62,000 | 91,000 | 139,000 |
| Interest Income Non Operating | 47,000 | 52,000 | 62,000 | 91,000 | 139,000 |
| Net Interest Income | 46,000 | 52,000 | 62,000 | 91,000 | 139,000 |
| Other Income Expense | -806,000 | 93,000 | 90,000 | 11,000 | 102,000 |
| Other Non Operating Income Expenses | -911,000 | 193,000 | -- | 5,000 | 8,000 |
| Gain On Sale Of Security | 105,000 | -100,000 | 90,000 | 6,000 | 102,000 |
| Pretax Income | -1.8M | -914,000 | -580,000 | -809,000 | -724,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.8M | -889,000 | -573,000 | -330,000 | -695,000 |
| Net Income From Continuing Operation Net Minority Interest | -1.8M | -889,000 | -573,000 | -330,000 | -695,000 |
| Net Income Including Noncontrolling Interests | -1.8M | -914,000 | -580,000 | -352,000 | -724,000 |
| Minority Interests | -15,000 | 25,000 | 7,000 | 22,000 | 29,000 |
| Net Income Common Stockholders | -1.8M | -889,000 | -573,000 | -330,000 | -695,000 |
| Net Income | -1.8M | -889,000 | -573,000 | -330,000 | -695,000 |
| EBITDA | -1.7M | -911,000 | -729,000 | -806,000 | -721,000 |
| Normalized EBITDA | -1.9M | -811,000 | -819,000 | -812,000 | -823,000 |
| Reconciled Depreciation | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Basic EPS | -0.02 | -0.01 | -0.01 | -- | -0.01 |
| Diluted EPS | -0.02 | -0.01 | -0.01 | -- | -0.01 |
| Basic Average Shares | 72.1M | 68.7M | 68.4M | -- | 68.4M |
| Diluted Average Shares | 72.1M | 68.7M | 68.4M | -- | 68.4M |
| Total Unusual Items | 105,000 | -100,000 | 90,000 | 6,000 | 102,000 |
| Total Unusual Items Excluding Goodwill | 105,000 | -100,000 | 90,000 | 6,000 | 102,000 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.9M | -789,000 | -663,000 | -336,000 | -797,000 |
| Diluted NI Availto Com Stockholders | -1.8M | -889,000 | -573,000 | -330,000 | -695,000 |
| Net Income Continuous Operations | -1.8M | -914,000 | -580,000 | -352,000 | -724,000 |
| Net Non Operating Interest Income Expense | 46,000 | 52,000 | 62,000 | 91,000 | 139,000 |
| Other Gand A | 907,000 | 944,000 | 625,000 | 849,000 | 703,000 |
| Reconciled Cost Of Revenue | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Salaries And Wages | 76,000 | 77,000 | 79,000 | 12,000 | 195,000 |
| Total Expenses | 991,000 | 1.1M | 732,000 | 911,000 | 965,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 10.4M | 12.1M | 9.2M | 11.0M | 12.6M |
| Cash Cash Equivalents And Short Term Investments | 10.4M | 12.1M | 9.2M | 11.0M | 12.6M |
| Cash Financial | 10.4M | 12.1M | -- | 11.0M | -- |
| Receivables | 191,000 | 174,000 | 202,000 | 181,000 | 979,000 |
| Prepaid Assets | 238,000 | 248,000 | 287,000 | 336,000 | 707,000 |
| Current Assets | 11.3M | 12.6M | 9.7M | 11.5M | 14.3M |
| Gross PPE | 151.5M | 150.7M | 149.3M | 148.0M | 147.0M |
| Accumulated Depreciation | -148,000 | -144,000 | -141,000 | -138,000 | -135,000 |
| Net PPE | 151.4M | 150.5M | 149.1M | 147.9M | 146.8M |
| Investments And Advances | 325,000 | 639,000 | 750,000 | 636,000 | 664,000 |
| Other Non Current Assets | 435,000 | 440,000 | 383,000 | 384,000 | 362,000 |
| Total Non Current Assets | 153.2M | 152.6M | 151.2M | 149.8M | 147.9M |
| Total Assets | 164.5M | 165.1M | 160.9M | 161.3M | 162.1M |
| Accounts Payable | 1.5M | 1.5M | 1.5M | 2.1M | 1.8M |
| Payables | 1.5M | 1.5M | 1.5M | 2.1M | 1.8M |
| Payables And Accrued Expenses | 1.5M | 1.5M | 1.5M | 2.1M | 1.8M |
| Current Liabilities | 1.5M | 1.5M | 1.5M | 2.1M | 1.8M |
| Total Non Current Liabilities Net Minority Interest | 10.7M | 10.7M | 10.7M | 10.7M | 11.1M |
| Total Liabilities Net Minority Interest | 12.1M | 12.2M | 12.2M | 12.8M | 12.9M |
| Common Stock | 241.9M | 241.9M | 237.5M | 237.5M | 237.5M |
| Capital Stock | 241.9M | 241.9M | 237.5M | 237.5M | 237.5M |
| Retained Earnings | -123.5M | -121.7M | -120.9M | -120.3M | -119.9M |
| Gains Losses Not Affecting Retained Earnings | 31.6M | 30.4M | 29.7M | 29.0M | 29.3M |
| Common Stock Equity | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Stockholders Equity | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Total Equity Gross Minority Interest | 152.4M | 153.0M | 148.7M | 148.5M | 149.2M |
| Minority Interest | 2.4M | 2.3M | 2.4M | 2.4M | 2.3M |
| Total Capitalization | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Net Tangible Assets | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Tangible Book Value | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Working Capital | 9.9M | 11.0M | 8.2M | 9.4M | 12.5M |
| Invested Capital | 150.1M | 150.6M | 146.3M | 146.2M | 146.9M |
| Share Issued | 72.1M | 72.1M | 68.4M | 68.4M | 68.4M |
| Ordinary Shares Number | 72.1M | 72.1M | 68.4M | 68.4M | 68.4M |
| Assets Held For Sale Current | 512,000 | -- | -- | -- | -- |
| Dueto Related Parties Current | -- | -- | -- | -- | -- |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 325,000 | 639,000 | -- | 636,000 | -- |
| Investmentin Financial Assets | 325,000 | 639,000 | 750,000 | 636,000 | 664,000 |
| Long Term Provisions | 360,000 | 364,000 | 371,000 | 371,000 | 350,000 |
| Non Current Accounts Receivable | 1.1M | 978,000 | 918,000 | 881,000 | -- |
| Non Current Deferred Liabilities | 10.3M | 10.3M | 10.3M | 10.3M | 10.7M |
| Non Current Deferred Taxes Liabilities | 10.3M | 10.3M | 10.3M | 10.3M | 10.7M |
| Other Receivables | 191,000 | 174,000 | 202,000 | 181,000 | 979,000 |
| Trading Securities | -- | -- | 750,000 | -- | 664,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.2M | -867,000 | -987,000 | -476,000 | -1.1M |
| Cash Flow From Continuing Operating Activities | -1.2M | -867,000 | -987,000 | -477,000 | -1.1M |
| Depreciation And Amortization | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Depreciation Amortization Depletion | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Stock Based Compensation | 76,000 | 77,000 | 79,000 | 12,000 | 195,000 |
| Change In Working Capital | -241,000 | -119,000 | -374,000 | 281,000 | -508,000 |
| Change In Receivables | -48,000 | -130,000 | 90,000 | -15,000 | -198,000 |
| Change In Payables And Accrued Expense | -193,000 | 11,000 | -464,000 | 296,000 | -310,000 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Purchase Of PPE | 0.00 | 0.00 | 0.00 | 98,000 | -- |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 94,000 | 14,000 |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | -181,000 | 0.00 |
| Sale Of Investment | 461,000 | 19,000 | -- | -- | -- |
| Net Investment Purchase And Sale | 461,000 | 19,000 | 0.00 | 46,000 | 0.00 |
| Investing Cash Flow | -561,000 | -662,000 | -777,000 | -1.3M | -920,000 |
| Cash Flow From Continuing Investing Activities | -561,000 | -662,000 | -777,000 | -1.3M | -919,000 |
| Issuance Of Capital Stock | -24,000 | 4.4M | -- | -- | -- |
| Net Common Stock Issuance | -24,000 | 4.4M | -- | -- | -- |
| Financing Cash Flow | -24,000 | 4.4M | -- | 225,000 | 0.00 |
| Cash Flow From Continuing Financing Activities | -24,000 | 4.4M | -- | 225,000 | 0.00 |
| Effect Of Exchange Rate Changes | 3,000 | 2,000 | 3,000 | -37,000 | 0.00 |
| Changes In Cash | -1.7M | 2.9M | -1.8M | -1.6M | -2.0M |
| Beginning Cash Position | 12.1M | 9.2M | 11.0M | 12.6M | 14.7M |
| End Cash Position | 10.4M | 12.1M | 9.2M | 11.0M | 12.6M |
| Free Cash Flow | -1.2M | -867,000 | -987,000 | -378,000 | -1.1M |
| Common Stock Issuance | -24,000 | 4.4M | -- | -- | -- |
| Depreciation | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Net Foreign Currency Exchange Gain Loss | -4,000 | -7,000 | 0.00 | 29,000 | -58,000 |
| Net Income From Continuing Operations | -1.8M | -914,000 | -580,000 | -352,000 | -724,000 |
| Net Other Investing Changes | -1.0M | -681,000 | -777,000 | -1.5M | -934,000 |
| Operating Gains Losses | 907,000 | -7,000 | -- | -- | -58,000 |
| Proceeds From Stock Option Exercised | -- | -- | -- | 225,000 | 0.00 |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | -4,000 | 14,000 |
| Unrealized Gain Loss On Investment Securities | -147,000 | 93,000 | -115,000 | -18,000 | -36,000 |